Growth Metrics

Moderna (MRNA) Return on Assets (2019 - 2025)

Moderna (MRNA) has disclosed Return on Assets for 7 consecutive years, with 0.23% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 1.0% to 0.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.23% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.21% for FY2025, 1.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.23% at Moderna, up from 0.26% in the prior quarter.
  • The five-year high for Return on Assets was 0.56% in Q1 2022, with the low at 0.36% in Q2 2024.
  • Average Return on Assets over 5 years is 0.04%, with a median of 0.04% recorded in 2023.
  • The sharpest move saw Return on Assets soared 66bps in 2021, then tumbled -62bps in 2023.
  • Over 5 years, Return on Assets stood at 0.54% in 2021, then plummeted by -40bps to 0.32% in 2022, then tumbled by -177bps to 0.25% in 2023, then rose by 4bps to 0.24% in 2024, then increased by 3bps to 0.23% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.23%, 0.26%, and 0.23% for Q4 2025, Q3 2025, and Q2 2025 respectively.